BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26286683)

  • 1. Sample size calculation for meta-epidemiological studies.
    Giraudeau B; Higgins JP; Tavernier E; Trinquart L
    Stat Med; 2016 Jan; 35(2):239-50. PubMed ID: 26286683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Label-invariant models for the analysis of meta-epidemiological data.
    Rhodes KM; Mawdsley D; Turner RM; Jones HE; Savović J; Higgins JPT
    Stat Med; 2018 Jan; 37(1):60-70. PubMed ID: 28929507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Finding Alternatives to the Dogma of Power Based Sample Size Calculation: Is a Fixed Sample Size Prospective Meta-Experiment a Potential Alternative?
    Tavernier E; Trinquart L; Giraudeau B
    PLoS One; 2016; 11(6):e0158604. PubMed ID: 27362939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size determinations for stepped-wedge clinical trials from a three-level data hierarchy perspective.
    Heo M; Kim N; Rinke ML; Wylie-Rosett J
    Stat Methods Med Res; 2018 Feb; 27(2):480-489. PubMed ID: 26988927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of bias: a simulation study of power to detect study-level moderator effects in meta-analysis.
    Hempel S; Miles JN; Booth MJ; Wang Z; Morton SC; Shekelle PG
    Syst Rev; 2013 Nov; 2():107. PubMed ID: 24286208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simulation-based power calculations for planning a two-stage individual participant data meta-analysis.
    Ensor J; Burke DL; Snell KIE; Hemming K; Riley RD
    BMC Med Res Methodol; 2018 May; 18(1):41. PubMed ID: 29776399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based sample size calculations based upon updated meta-analysis.
    Sutton AJ; Cooper NJ; Jones DR; Lambert PC; Thompson JR; Abrams KR
    Stat Med; 2007 May; 26(12):2479-500. PubMed ID: 16981184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size calculation for clinical trials with correlated count measurements based on the negative binomial distribution.
    Li D; Zhang S; Cao J
    Stat Med; 2019 Dec; 38(28):5413-5427. PubMed ID: 31652010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using information from network meta-analyses to optimize the power and sample allocation of a subsequent trial with a new treatment.
    Hu D; Wang C; Ye F; O'Connor AM
    BMC Med Res Methodol; 2022 Nov; 22(1):299. PubMed ID: 36418960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A note on sample size calculations for cluster randomised crossover trials with a fixed number of clusters.
    Kelly TL; Pratt N
    Stat Med; 2019 Aug; 38(18):3342-3345. PubMed ID: 31069820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Power and Sample Size Calculations in Clinical Trials with Patient-Reported Outcomes under Equal and Unequal Group Sizes Based on Graded Response Model: A Simulation Study.
    Doostfatemeh M; Taghi Ayatollah SM; Jafari P
    Value Health; 2016; 19(5):639-47. PubMed ID: 27565281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample size considerations for split-mouth design.
    Zhu H; Zhang S; Ahn C
    Stat Methods Med Res; 2017 Dec; 26(6):2543-2551. PubMed ID: 26303156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A flexible approach to identify interaction effects between moderators in meta-analysis.
    Li X; Dusseldorp E; Meulman JJ
    Res Synth Methods; 2019 Mar; 10(1):134-152. PubMed ID: 30511514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trial sequential methods for meta-analysis.
    Kulinskaya E; Wood J
    Res Synth Methods; 2014 Sep; 5(3):212-20. PubMed ID: 26052847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.
    Brookes ST; Whitley E; Peters TJ; Mulheran PA; Egger M; Davey Smith G
    Health Technol Assess; 2001; 5(33):1-56. PubMed ID: 11701102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A general approach for sample size and statistical power calculations assessing of interventions using a mixture model in the presence of detection limits.
    Nie L; Chu H; Cole SR
    Contemp Clin Trials; 2006 Oct; 27(5):483-91. PubMed ID: 16769254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size calculations for comparing two groups of count data.
    Wang L; Fan C
    J Biopharm Stat; 2019; 29(1):115-127. PubMed ID: 30024833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between statistical power and predictor distribution in multilevel logistic regression: a simulation-based approach.
    Olvera Astivia OL; Gadermann A; Guhn M
    BMC Med Res Methodol; 2019 May; 19(1):97. PubMed ID: 31072299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simplification and implementation of random-effects meta-analyses based on the exact distribution of Cochran's Q.
    Preuß M; Ziegler A
    Methods Inf Med; 2014; 53(1):54-61. PubMed ID: 24317521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical methods for meta-analyses including information from studies without any events-add nothing to nothing and succeed nevertheless.
    Kuss O
    Stat Med; 2015 Mar; 34(7):1097-116. PubMed ID: 25446971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.